Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
- Eric Murillo-Rodríguez(corresponding author),
- Marcela Palomero-Rivero,
- Diana Millán-Aldaco,
- Raphael Mechoulam,
- René Drucker-Colín
- ,
- Universidad Nacional Autónoma de México,
- Hebrew University of Jerusalem
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 504-511 (8 pages)Journal (Volume, Issue Number)
Life Sciences (Volume 88, Issue 11-12)Publication milestones
- Published - 14/03/2011
Publication status
ISSN
0024-3205Publication IDs
- Scopus: 79952438369
- PubMed: 21262236
Abstract
Aims: The major non-psychoactive component of Cannabis sativa, cannabidiol (CBD), displays a plethora of actions including wakefulness. In the present study, we addressed whether perfusing CBD via microdialysis into lateral hypothalamus (LH) during the lights-on period would modify the sleep-wake cycle of rats as well as the contents of dopamine (DA) collected from nucleus accumbens (AcbC). Additionally, we tested whether perfusion of CBD into LH would block the sleep rebound after a sleep deprivation period. Main methods: Electroencephalogram and electromyogram electrodes were implanted in rats as well as a guide-cannula aimed to LH or AcbC. CBD perfusion was carried out via cannulae placed into LH whereas contents of DA were collected from AcbC and analyzed using HPLC means. Key findings: We found that microdialysis perfusion of CBD (30, 60, or 90 nM) into LH of rat enhances alertness and suppresses sleep. This effect was accompanied with an increase in DA extracellular levels collected from the AcbC. Furthermore, perfusion of CBD into LH after total sleep deprivation prevented the sleep rebound. Significance: These findings enhance the investigation about the neurobiological properties of CBD on sleep modulation.
